Knee arthroplasty surgery is a highly effective treatment for arthritis and disorders of the knee. There are a wide variety of implant brands and types of knee arthroplasty available to surgeons. As a result of a number of highly publicized failures, arthroplasty surgery is highly regulated in the UK and many other countries through national registries, introduced to monitor implant performance, surgeons, and hospitals. With time, the options available within many brand portfolios have grown, with alternative tibial or femoral components, tibial insert materials, or shapes and patella resurfacings. In this study we have investigated the effect of the expansion of implant brand portfolios and where there may be a lack of transparency around a brand name. We also aimed to establish the potential numbers of compatible implant construct combinations. Hypothetical implant brand portfolios were proposed, and the number of compatible implant construct combinations was calculated.Aims
Methods
Current analysis of unicondylar knee replacements
(UKRs) by national registries is based on the pooled results of medial
and lateral implants. Consequently, little is known about the differential
performance of medial and lateral replacements and the influence
of each implant type within these pooled analyses. Using data from
the National Joint Registry for England and Wales (NJR) we aimed
to determine the proportion of UKRs implanted on the lateral side
of the knee, and their survival and reason for failure compared
with medial UKRs. By combining information on the side of operation
with component details held on the NJR, we were able to determine
implant laterality (medial